Literature DB >> 27920894

Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.

Marzia Marciello1, Juan Pellico2, Irene Fernandez-Barahona2, Fernando Herranz3, Jesus Ruiz-Cabello4, Marco Filice2.   

Abstract

Nowadays, thanks to the successful discoveries in the biomedical field achieved in the last two decades, a deeper understanding about the complexity of mechanistic aspects of different pathological processes has been obtained. As a consequence, even the standard therapeutic protocols have undergone a vast redesign. In fact, the awareness about the necessity to progress towards a combined multitherapy in order to potentially increase the final healing chances has become a reality. One of the crucial elements of this novel approach is that large amounts of detailed information are highly needed and in vivo imaging techniques represent one of the most powerful tools to visualize and monitor the pathological state of the patient. To this scope, due to their unique features, nanostructured materials have emerged as attractive elements for the development of multifunctional tools for diagnosis and therapy. Hence, in this review, the most recent and relevant advances achieved by applying multifunctional nanostructures in multimodal theranosis of different diseases will be discussed. In more detail, the preparation and application of single multifunctional nano-radiotracers based on iron oxides and enabling PET/MRI dual imaging will be firstly detailed. After that, especially considering their highly promising clinical potential, the preparation and application of multifunctional liposomes useful for multimodal imaging and therapy will be reviewed. In both cases, a special focus will be set on the application of such a multifunctional nanocarriers in cancer as well as cardiovascular diseases.

Entities:  

Keywords:  PET/MRI; iron oxide nanoparticles; liposome; molecular imaging; multimodal imaging; theranosis

Year:  2016        PMID: 27920894      PMCID: PMC5071816          DOI: 10.1098/rsfs.2016.0055

Source DB:  PubMed          Journal:  Interface Focus        ISSN: 2042-8898            Impact factor:   3.906


  118 in total

Review 1.  The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.

Authors:  Eva Lonn; Jackie Bosch; Koon K Teo; Prem Pais; Denis Xavier; Salim Yusuf
Journal:  Circulation       Date:  2010-11-16       Impact factor: 29.690

Review 2.  Emerging implications of nanotechnology on cancer diagnostics and therapeutics.

Authors:  Alex G Cuenca; Huabei Jiang; Steven N Hochwald; Matthew Delano; William G Cance; Stephen R Grobmyer
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

Review 3.  Superparamagnetic iron oxide nanoparticle probes for molecular imaging.

Authors:  Daniel L J Thorek; Antony K Chen; Julie Czupryna; Andrew Tsourkas
Journal:  Ann Biomed Eng       Date:  2006-02-16       Impact factor: 3.934

4.  A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging.

Authors:  Jin-sil Choi; Jeong Chan Park; Hyunsoo Nah; Seungtae Woo; Jieun Oh; Kyeong Min Kim; Gi Jeong Cheon; Yongmin Chang; Jeongsoo Yoo; Jinwoo Cheon
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 5.  Nanoparticle-assisted combination therapies for effective cancer treatment.

Authors:  Che-Ming Jack Hu; Santosh Aryal; Liangfang Zhang
Journal:  Ther Deliv       Date:  2010-08

Review 6.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

Review 7.  Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Authors:  Padmanee Sharma; James P Allison
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

8.  Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.

Authors:  Erik de Blois; Ho Sze Chan; Clive Naidoo; Deidre Prince; Eric P Krenning; Wouter A P Breeman
Journal:  Appl Radiat Isot       Date:  2010-11-23       Impact factor: 1.513

9.  Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.

Authors:  Thorsten D Poeppel; Ina Binse; Stephan Petersenn; Harald Lahner; Matthias Schott; Gerald Antoch; Wolfgang Brandau; Andreas Bockisch; Christian Boy
Journal:  Recent Results Cancer Res       Date:  2013

10.  Emerging role of radiolabeled nanoparticles as an effective diagnostic technique.

Authors:  Andréluís Branco de Barros; Andrew Tsourkas; Babak Saboury; Valbert Nascimento Cardoso; Abass Alavi
Journal:  EJNMMI Res       Date:  2012-07-18       Impact factor: 3.138

View more
  4 in total

1.  AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer.

Authors:  Jingjing Li; Qing Li; Meijuan He; Fan Ding; Lulu Cai; Mingming Zhao; Lina Dong; Qi Wang; Kai Xu
Journal:  RSC Adv       Date:  2019-10-29       Impact factor: 4.036

Review 2.  Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging.

Authors:  Juan Pellico; Jordi Llop; Irene Fernández-Barahona; Riju Bhavesh; Jesús Ruiz-Cabello; Fernando Herranz
Journal:  Contrast Media Mol Imaging       Date:  2017-11-21       Impact factor: 3.161

Review 3.  Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.

Authors:  Umberto Tosi; Christopher S Marnell; Raymond Chang; William C Cho; Richard Ting; Uday B Maachani; Mark M Souweidane
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

4.  Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capability.

Authors:  Alexis Alvear-Jiménez; Irene Zabala Gutierrez; Yingli Shen; Gonzalo Villaverde; Laura Lozano-Chamizo; Pablo Guardia; Miguel Tinoco; Beatriz Garcia-Pinel; José Prados; Consolación Melguizo; Manuel López-Romero; Daniel Jaque; Marco Filice; Rafael Contreras-Cáceres
Journal:  Pharmaceutics       Date:  2022-01-17       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.